Skip to main content

Latest SEC Filings — Page 128

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

IPG Photonics Reports Strong Q1 Revenue Growth, Mixed Profitability, and Global Patent Litigation Settlement
ProForm 8-KIPGP · Form 8-K · 4d ago
Spyre Therapeutics Secures $435M in Public Offering and Reports Positive SPY001 Phase 2 Data
ProForm 10-QSYRE · Form 10-Q · 4d ago
Activist Investor Ascent Capital Declares Victory, Shifts to Inactive Stance Citing Major Operational & Governance Improvements
ProForm SCHEDULE 13D/AINV · Form SCHEDULE 13D/A · 4d ago
WEX Settles Proxy Battle with Impactive Capital, Reshapes Board and Postpones Annual Meeting
ProForm DEFA14AWEX · Form DEFA14A · 4d ago
Sunstone Hotel Investors Reports Strong Q1, Raises Full-Year Guidance, and Executes Substantial Share Repurchases
ProForm 8-KSHO · Form 8-K · 4d ago
Knife River Reports Q1 2026 Results, Projects $3.3B-$3.5B Full-Year Revenue & $520M-$560M Adjusted EBITDA
Form 8-KKNF · Form 8-K · 4d ago
Enovix Aligns with Lead Smartphone Customer on Qualification, Hires Sales VP for Commercial Scale-Up
ProForm 8-KENVX · Form 8-K · 4d ago
Core AI Appoints Former Meta Data Center Leader Sonali Garg to Advisory Board, Strengthening Joint Venture Execution
Form 6-KCHAI · Form 6-K · 4d ago
Lindblad Expeditions Reports Record Q1 2026 Results with 16% Revenue & EBITDA Growth, Highest Occupancy
Form 8-KLIND · Form 8-K · 4d ago
Shoals Technologies Reports Strong Revenue Growth Amidst Significant Cash Burn and Liquidity Concerns
ProForm 10-QSHLS · Form 10-Q · 4d ago
High Tide Secures $40M Credit Facilities from Big 5 Canadian Bank, Validating Business Model
ProForm 6-KHITI · Form 6-K · 4d ago
Rhythm Pharma Reports Strong Q1 Revenue Growth, Successful IMCIVREE Launch, and European/Japanese Expansion
Form 8-KRYTM · Form 8-K · 4d ago
Peabody Energy Reports Q1 Net Loss, Significant EBITDA Decline, and Reduced Centurion Mine Guidance
ProForm 8-KBTU · Form 8-K · 4d ago
Cameco Reports Strong Q1 2026 Earnings with Significant Profit Growth; Uranium Segment Drives Performance Amidst Bullish Nuclear Market
Form 6-KCCJ · Form 6-K · 4d ago
Climb Bio Reports Positive Subcutaneous Formulation Data for Budoprutug and Confirms Multiple Upcoming Clinical Milestones
ProForm 8-KCLYM · Form 8-K · 4d ago
Vodafone to Acquire Full Ownership of VodafoneThree for £4.3 Billion
ProForm 6-KVOD · Form 6-K · 4d ago
Cummins Raises Full-Year Revenue & Profit Outlook After Strong Q1 Sales Beat
ProForm 8-KCMI · Form 8-K · 4d ago
Energy Transfer Reports Strong Q1 Results, Raises Full-Year Adjusted EBITDA Guidance
ProForm 8-KET · Form 8-K · 4d ago
Nuvectis Pharma Reports Widened Q1 Net Loss and Significant Cash Burn, Advances NXP900 Clinical Program
Form 8-KNVCT · Form 8-K · 4d ago
Sphere Entertainment Reports Strong Q1 2026 Results, Swings to Profit
ProForm 8-KSPHR · Form 8-K · 4d ago
Surgery Partners Reports Q1 2026 Results, Reaffirms Full-Year Guidance
Form 8-KSGRY · Form 8-K · 4d ago
Westlake Reports Q1 Net Loss of $169M, Cites Sequential Improvements and $600M EBITDA Uplift Plan
Form 8-KWLK · Form 8-K · 4d ago
Westlake Chemical Partners Reports Strong Q1 Earnings, Net Income Jumps 187% YoY
ProForm 8-KWLKP · Form 8-K · 4d ago
Sow Good Secures $20M Non-Convertible Credit Facility to Fund Critical Minerals Pivot
ProForm 8-KSOWG · Form 8-K · 4d ago
Compass Therapeutics Reports Strong Q1 Financials, $195M Cash Runway into 2028, and Advances Key Oncology Programs
Form 8-KCMPX · Form 8-K · 4d ago
Leonardo DRS Reports Strong Q1 Results, Beats Expectations, and Raises Full-Year Guidance
ProForm 8-KDRS · Form 8-K · 4d ago
Ocular Therapeutix Details Positive AXPAXLI Phase 3 Results, Confirms NDA Plan, and Updates Q1 Financials
ProForm 10-QOCUL · Form 10-Q · 4d ago
Havertys Reports Strong Q1 Earnings with 13% EPS Growth and Increased Capex for Store Expansion
ProForm 8-KHVT · Form 8-K · 4d ago
WEC Energy Group Reports Strong Q1 Earnings, Beats Revenue Estimates, Reaffirms 2026 Guidance
Form 8-KWEC · Form 8-K · 4d ago
Cipher Digital Reports Q1 Loss, Secures Hyperscale Lease & $200M Credit Facility
ProForm 8-KCIFR · Form 8-K · 4d ago